DOI: 10.1055/s-00035024

Thrombosis and Haemostasis

References

Chi G, Yee MK, Amin AN. , et al.
Extended-duration betrixaban reduces the risk of rehospitalization associated with venous thromboembolism among acutely ill hospitalized medical patients: findings from the APEX trial (acute medically ill venous thromboembolism prevention with extended duration betrixaban trial).

Circulation 2018;
137 (01) 91-94

Chi G, Yee MK, Amin AN. , et al.
Extended-duration betrixaban reduces the risk of rehospitalization associated with venous thromboembolism among acutely ill hospitalized medical patients: findings from the APEX trial (acute medically ill venous thromboembolism prevention with extended duration betrixaban trial).

Circulation 2018;
137 (01) 91-94

Download Bibliographical Data

Search in:
Access: